Completed OBSERVATIONAL NCT02407964

A Retrospective Study on Drug Induced Liver Injury in China (DILI-R)

A Retrospective Epidemiologic Study on Incidence and Treatment Status of Hospitalized Drug Induced Liver Injury Patients in Mainland China

Sponsor: Drug Induced Liver Disease Study Group

Conditions Drug-Induced Liver Injury

Updated 7 times since 2017 Last updated: Oct 24, 2016 Started: Mar 31, 2015 Primary completion: May 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02407964, this observational or N/A phase trial focuses on Drug-Induced Liver Injury and remains completed. Sponsored by Drug Induced Liver Disease Study Group, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Drug Induced Liver Disease Study Group
Unimed Scientific Inc.

Data source: Drug Induced Liver Disease Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ankang, China , Anqing, China , Baoding, China , Baoji, China , Baotou, China , Beijing, China , Bengbu, China , Cangzhou, China , Changchun, China , Changji, China and 123 more locations